angiotensin ii, des-phe(8)- has been researched along with muscimol in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (muscimol) | Trials (muscimol) | Recent Studies (post-2010) (muscimol) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 4,699 | 9 | 887 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fontes, MA; Santos, RA; Silva, AQ | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and muscimol
| Article | Year |
|---|---|
Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Imidazoles; Kidney; Microinjections; Muscimol; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sympathetic Nervous System | 2005 |